Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MEdical Treatment in Idiopathic Ventricular Fibrillation Patients — Stella

Home/Idiopathic Ventricular Fibrillation/MEdical Treatment in Idiopathic Ventricular Fibrillation Patients

View on ClinicalTrials.gov

Recruiting

Back to Idiopathic Ventricular Fibrillation trials

MEdical Treatment in Idiopathic Ventricular Fibrillation Patients

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Denmark

The Heart Center, Rigshospitalet, Copenhagen, Dr.

Odense University Hospital, Odense

Key details

Phase

Post-approval study

Sponsor

Bo Gregers Winkel

Collaborators

The Novo Nordisk Foundation, Per Henriksen Foundation

Enrollment target

~218 participants

Started

May 2018

Primary completion

December 2032

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.